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SHANK3 is a synaptic scaffolding protein enriched in the postsynaptic density (PSD) of excitatory synapses.
Small microdeletions and point mutations in SHANK3 have been identified in a small subgroup of individuals
with autism spectrum disorder (ASD) and intellectual disability. SHANK3 also plays a key role in the chromo-
some 22q13.3 microdeletion syndrome (Phelan–McDermid syndrome), which includes ASD and cognitive
dysfunction as major clinical features. To evaluate the role of Shank3 in vivo, we disrupted major isoforms
of the gene in mice by deleting exons 4–9. Isoform-specific Shank3e4 –9 homozygous mutant mice display
abnormal social behaviors, communication patterns, repetitive behaviors and learning and memory.
Shank3e4 – 9 male mice display more severe impairments than females in motor coordination. Shank3e4 – 9
mice have reduced levels of Homer1b/c, GKAP and GluA1 at the PSD, and show attenuated activity-depen-
dent redistribution of GluA1-containing AMPA receptors. Subtle morphological alterations in dendritic
spines are also observed. Although synaptic transmission is normal in CA1 hippocampus, long-term poten-
tiation is deficient in Shank3e4–9 mice. We conclude that loss of major Shank3 species produces biochemical,
cellular and morphological changes, leading to behavioral abnormalities in mice that bear similarities to
human ASD patients with SHANK3 mutations.
INTRODUCTION
Shank3 [SH3 and multiple ankyrin (ANK) repeat domain 3] is
a member of the highly conserved Shank/ProSAP family of
synaptic scaffolding proteins, first identified as a component
of the PSD-95/GKAP/Homer1 complex enriched in the
postsynaptic densities (PSDs) of excitatory synapses (1–3).
Shank3 is a large protein containing multiple conserved
motifs, including an ANK repeat, a proline-rich cluster and
SH3, PDZ and SAM (sterile a-motif) domains (4–6).
In vitro studies have shown that the ANK domain can interact
with cytoskeletal proteins in the PSD (7), the proline-rich
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domain of Shank3 can interact with Homer1b/c protein (2) and
the PDZ domain can interact with the GluA1 subunit of the
AMPA receptor (AMPAR) directly, and with the NMDA
receptor (NMDAR) through GKAP and the PSD-95 complex
(1,2,8). In hippocampal cultures, expression of Shank3 in
aspiny neurons can recruit AMPARs for the formation of
new synapses, and siRNA-induced knockdown of Shank3
reduces spine densities and increases the lengths of spines
(9). It remains unclear whether these interactions occur
in vivo and whether they can influence synaptic function.
SHANK3 maps to the critical region of chromosome
22q13.3 deletion syndrome (also known as Phelan–McDermid
syndrome or PMS) (10–13). PMS patients present with promi-
nent autistic features, including severe language delay and
moderate-to-severe intellectual disability (14,15). Heterozy-
gous microdeletions and point mutations, including de novo
missense and frame-shift mutations of SHANK3, are reported
in a small subgroup of individuals with autism spectrum dis-
order (ASD) with comorbidity for intellectual disability
(16–21). These and other reports suggest that haploinsuffi-
ciency of SHANK3 may play a key role in PMS and ASD
(11,12,22,23). Interestingly, mutations in SHANK3 have
been reported also in schizophrenia, suggesting that
SHANK3 deficiency may contribute to both neurobehavioral
disorders (20,21).
ASD is characterized by impairments in social behavior,
communication and language development, as well as by
repetitive and stereotyped behaviors (24–26); comorbidities
in intellectual disabilities and movement disorders are
common (27–29). A diagnosis of ASD in humans is purely
based on behavioral assessment. Although the condition is
diagnosed more often in males than in females, the basis for
this sex difference is unknown (30,31). While a genetic com-
ponent is strongly implicated in the etiology of ASD, the
underlying molecular and neuropathophysiological basis of
the condition is unknown in most ASD cases. Nevertheless,
de novo missense mutations in exons 5–9 encoding the
ANK domain of SHANK3 and microdeletions of the entire
SHANK3 gene have been reported in ASD (16–19). To inves-
tigate the possible role of Shank3 in ASD, we generated
mutant mice lacking exons 4–9 which encode the ANK
domain, disrupting expression of the major isoforms of
Shank3 (Shank3e4 – 9). These Shank3e4 – 9 homozygous
mutants were subjected to biochemical, cellular, electro-
physiological and behavioral analyses to elucidate the func-
tional significance of these major Shank3 proteins.
RESULTS
Generation of Shank3 mutant mice
We generated Shank3 mutant mice using a conventional gene-
targeting approach (32) where exons 4–9 of the Shank3 gene
were deleted (Fig. 1A, B and C and Supplementary Material,
Fig. S1A1 and A2). The naturally occurring Disc1 (Disrupted
in Schizophrenia 1) mutation in the 129SvEv line of ES cells
was segregated from Shank3e4 – 9 at the beginning of back-
crossing to avoid any possible confounding effects in our
experiments (Supplementary Material, Fig. S1A3) (33–35).
All Shank3 mice used in the experiments had been
backcrossed for more than seven generations onto a C57BL/
6J background.
Shank3 mRNA species and Shank3 isoform-specific
deletion
As predicted, a 940 bp RT-PCR product was identified in
Shank3 wild-type (Shank3+/+) mice, using primers anchoring
exons 2 and 10 (Fig. 1B). In contrast, two smaller products
(330 and 260 bp) were detected in Shank3e4 – 9 brains (Sup-
plementary Material, Fig. S1A4). Sequencing confirmed that
the 330 bp product represented a fragment joining exons 2, 3
and 10, whereas the 260 bp product represented cryptic spli-
cing from exons 2 to 10 (Supplementary Material,
Fig. S1A5). Both transcripts resulted in truncated proteins,
with premature stop codons in exon 11. Interestingly, the
260 bp transcript appears to be brain-specific, since it is not
found in Shank3e4 – 9 kidney (Supplementary Material,
Fig. S1A4).
Western blot was performed with an antibody raised against
amino acids 1431–1590 of the human SHANK3 protein
(Q9BYB0) (Supplementary Material, Table S4). According
to GenBank (AB231013), the full-length mouse Shank3
protein (i.e. isoform 3a) should be 190 kDa. A band of
this size was found in Shank3+/+ but it was completely
absent in Shank3e4 – 9 brain (Fig. 1D). Although the Shank3b
protein (AJ245904, 77 kDa) was predicted to be disrupted
in Shank3e4 – 9 mice, we were unable to confirm this, since
exon 21 is spliced out of this isoform and our antibody only
binds this portion of Shank3. However, we observed bands
at 140 and 170 kDa in both genotypes with our antibody.
These bands presumably represent different isoforms of
Shank3, although we were not able to determine the corre-
sponding mRNA transcripts.
The Shank3 gene has 22 exons and spans 58 kb of genomic
DNA. Alternative splicing of the SHANK3 gene has been
suggested (11,16,36) and we have identified five intragenic pro-
moters as well as extensive alternative splicing in mouse Shank3
(Fig. 1A). These promoters and splice forms were confirmed for
both humans and mice by 5′ RACE, RT-PCR, promoter–repor-
ter assays and in silico analyses (Fig. 1E and Supplementary
Material, Fig. S1). Sequences of these new transcripts are depos-
ited in GenBank (HQ405757-HQ405766 and HO7636
62-HO763663) (structures are found in Supplementary
Material, Fig. S1B1–B8). We have confirmed at least 11 differ-
ent Shank3 mRNA species in the mouse brain. The total number
of mRNA species produced by combinations of alternatively
spliced exons and multiple promoters is expected to be
sizable. Due to the limitations of our antibody, we were
unable to determine whether proteins are produced from all
the mRNA transcripts we have identified. Nonetheless, by
sequencing RT-PCR products, we have confirmed that tran-
scripts (Shank3a–b) initiated by promoters 1 and 2 are absent,
whereas transcripts (Shank3c–e) from promoters 3–5 are
present in the Shank3e4 – 9 brain (Fig. 1E). Transcript-specific
expression from promoter 6 (Shank3f) could not be verified,
because this promoter is embedded in exon 21, which is
shared by other isoforms. Nevertheless, we conclude that
Shank3e4 – 9 mice possess isoform-specific deletions in which
the major Shank3a and Shank3b species, as well as other
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novel short transcripts (Shank3a1–2 and Shank3b1–2), are dis-
rupted (Supplementary Material, Fig. S1B).
Social behavior is abnormal in Shank3e4 – 9 mice
Shank3e4 – 9 mice had normal Mendelian ratios at weaning, had
no apparent developmental defects and were viable and fertile
with a normal life span. The body weights of Shank3e4 – 9 mice
at 8–12 months of age were slightly higher than those of
Shank3+/+ animals (Supplementary Material, Fig. S5B), con-
sistent with the mild overgrowth seen in some human PMS
patients (14). However, the body weights of the mice at 3–4
months of age were not significantly different at the time of
behavioral testing (see Supplementary Material, Behavioral
studies). There were no differences for brain weights
between adult Shank3e4 – 9 and Shank3+/+ mice at 2–4
months of age (Supplementary Material, Fig. S5C).
We conducted extensive behavioral analyses on adult
Shank3e4 – 9 mice (3–6 months old and 4 cohorts of a total
of 50 Shank3e4 – 9 and 50 wild-type littermates from 21
litters of heterozygous breeding); detailed statistical analyses
for all behavioral results are provided in Supplementary
Material. Since social behavior is dependent upon olfaction,
this sense was evaluated in the Shank3 mice. No genotype
differences were observed for olfactory preferences for urine
from estrus females versus saline (Shank3+/+: 0.50+ 0.02;
Shank3e4 – 9: 0.41+ 0.2) or for urine from male breeders
versus saline (Shank3+/+: 0.51+ 0.04; Shank3e4 – 9:
0.43+ 0.4) or for total interaction times with the paired
stimuli (Shank3+/+: 236+ 4.2 and 235+ 7.2 s; Shank3e4 – 9:
242+ 4.3 and 228+ 6.7 s, respectively). Hence, both geno-
types are comparably able to discriminate urine from saline.
In a sociability test, both social affiliation and social prefer-
ence were examined. No stimulus preferences were observed
for either genotype during the identical non-social 1–non-
social 1 (NS1–NS1) pairing (Fig. 2A and B). In the NS1–
social 1 (NS1–Soc1) pairing, Shank3+/+ controls showed
higher affiliation for the novel social stimulus than
Figure 1. Generation and characterization of Shank3e4 – 9 mice. (A) A diagram of the structure of the murine Shank3 gene showing promoters and alternative
splicing sites (the asterisk indicates alternatively spliced exons). Five intragenic promoters were identified (see also Supplementary Material, Fig. S1B): ANK,
ankyrin repeats; SH3, Src homology 3 domain; PDZ, postsynaptic density protein, Drosophila disk large tumor suppressor (DlgA) and Zonula occludens-1
protein (Zo-1) domain proline-rich domain; SAM, sterile a-motif domain. (B) Genomic map and structure of the Shank3 gene covering exons 1–10 and the
targeting construct for the deletion of Shank3 exons 4–9. RT-F ¼ forward primers and RT-R ¼ reverse primer for RT-PCR analysis in Supplementary Material,
Fig. S1A4. (C) Genotyping of Shank3e4 – 9 mice by Southern blot with XbaI and the 3′ flanking probe. The 10.5 kb fragment is the wild-type band; the 6.4 kb
fragment is the mutant band. (D) Western blot analysis with Shank3e4 – 9 (–/–) brain samples; the 190, 170 and 140 kDa bands are seen in the Shank3+/+ (+/+)
brain and only the 140 and 170 kDa bands are in Shank3e4 – 9 samples. (E) RT-PCR analysis for specific Shank3 transcripts in Shank3e4 – 9 mice. Shank3a and
Shank3b transcripts were absent in Shank3e4 – 9 mice. Other transcripts (Shank3c–e) from promoters 3–5 were present in Shank3e4 – 9 mice.
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Shank3e4 – 9 mice. Shank3e4 – 9 females interacted with the
social stimulus more than Shank3e4 – 9 males. In the familiar
Soc1–novel social 2 (Soc1–Soc2) pairing, both genotypes—
regardless of sex—showed similar social preferences for the
novel animal. The reduced social affiliation in the NS1–
Soc1 pairing in Shank3e4 – 9 mice was not due to decreased
interaction times, since both genotypes spent similar
amounts of time investigating both stimuli, regardless of pair-
ings (Supplementary Material, Table S1). Additionally, the
numbers of contacts between NS1 and NS1 stimuli did not
differ between genotypes (Supplementary Material, Fig. S2A
and B). Although contacts declined for Shank3+/+ mice
when social stimuli were present, habituation was not
observed for Shank3e4 – 9 mice. Notably, Shank3e4 – 9 females
made more NS1–Soc1 contacts than the Shank3+/+ controls.
Together, these results indicate that when given a choice of
interacting with a social or non-social stimulus, Shank3e4 – 9
mice fail to show social affiliation. However, when forced to
choose between two social stimuli in the social preference
test, Shank3 mutants demonstrate social reference by prefer-
ring the novel animal.
Social behaviors were examined also in a dyadic test. Pre-test
responses were not differentiated by genotype (Supplementary
Material, Table S1). Shank3+/+ controls spent more time in
bidirectional social interactions than Shank3e4 – 9 mice
(Fig. 2C). Latency to the first bidirectional social interaction
was shorter in Shank3+/+ than in Shank3e4 – 9 mice, and was
most protracted in mutant females (Fig. 2D). None of the
Shank3e4 – 9 mice initiated the first social interaction; all
initiations were by C3H partners. By comparison, 50% of
the social exchanges between Shank3+/+ targets and C3H part-
ners were initiated by targets, regardless of sex.
A dyadic test was used to analyze a broad range of social
responses. Shank3+/+ males spent less time investigating
Figure 2. Sociability and interaction as well as ultrasonic communications are abnormal in Shank3e4 – 9 mice. (A and B) No genotype or sex differences are evident
for preferences between the identical NS objects. In the NS1–Soc1 pairing, Shank3+/+ (+/+) males and females prefer the novel Soc stimulus; Shank3e4 – 9 (–/–)
males and females show no or reduced preferences for this stimulus. When presented with familiar and novel Soc stimuli, all mice prefer the novel social partner. (C)
In the dyadic test, Shank3e4 – 9 mice participate in bidirectional social exchanges with C3H partners for shorter periods of time than Shank3+/+ controls and their
partners. (D) Shank3e4 – 9 mice take longer to initiate their first social interaction than Shank3+/+ mice. (E and F) Both male (E) and female (F) Shank3e4 – 9
mice and their respective C3H partners show reduced times in social interactions than the respective Shank3+/+ targets and their C3H partners; n ¼ 10 mice/geno-
type/sex. ∗P , 0.05, Shank3+/+ versus Shank3e4 – 9 mice; #P , 0.05, females versus males within genotype; ‡P , 0.05, compared with the NS1–NS1 test within
genotype; ¤P , 0.05, compared with the NS1–Soc1 test within genotype; &P , 0.05, target versus partner within genotype; vP , 0.05, Shank3+/+ social partner
versus Shank3e4 – 9 partner (see Supplementary Material, Fig. S2 and Table S1). (G) Shank3e4 – 9 males emit more and Shankee4 – 9 females produce fewer calls relative
to Shank3+/+ controls. (H) Representative spectrographs of ultrasonic calls for male and female Shank3+/+ and Shank3e4 – 9 mice. (I and J) The calls emitted by
Shank3+/+ mice are primarily of long duration, whereas those by Shank3e4 – 9 mice are mostly of short duration. (K and L) Shank3+/+ males produce more mid-range
and high-frequency calls of longer duration than Shank3e4 – 9 males. Durations did not vary across frequencies for Shank3e4 – 9 mice; however, durations of high-
frequency calls by Shank3e4 – 9 females were shorter than those by other groups; n ¼ 10 mice/genotype/sex. ∗P , 0.05, Shank3+/+ versus Shank3e4 – 9 mice; #P
, 0.05, females versus males within genotype; !P , 0.05, compared with short duration or low-frequency calls; ¼P , 0.05, compared with moderate duration
or mid-range frequency calls.
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their partners than Shank3+/+ females (Fig. 2E and F). None-
theless, investigation times by Shank3e4 – 9 mice were lower
than Shank3+/+ mice and their C3H partners. Possibly due
to this reduction, C3H partners of Shank3e4 – 9 mice engaged
in fewer social investigations than pairings with Shank3+/+
controls. Although investigations were reduced, Shank3e4 – 9
mice spent more time self-grooming and sifting through
bedding materials than Shank3+/+ mice (Supplementary
Material, Fig. S2C and D); Shank3+/+ controls and their
C3H partners rarely engaged in these behaviors. Collectively,
these data show that Shank3e4 – 9 mice engage in fewer social
interactions and are more likely to participate in non-social
self-focused behaviors than Shank3+/+ mice. Additionally,
social investigations are decreased in C3H partners to
Shank3e4 – 9 mice, indicating that the partners are less likely
to sustain interactions with non-socially responsive mice.
Ultrasonic vocalizations are aberrant in Shank3e4 – 9 mice
Ultrasonic communication was examined by exposing Shank3
mice to a non-familiar C3H mouse where no physical inter-
action could occur. Prior to mouse presentation, no ultrasonic
calls were recorded. At the presentation of the C3H mice, the
numbers of vocalizations by Shank3+/+ males and females
were similar (Fig. 2G). However, Shank3e4 – 9 males made sig-
nificantly more calls, and Shank3e4 – 9 females made signifi-
cantly fewer calls, than Shank3+/+ mice. The vocal
spectrograms revealed that Shank3+/+ mice produced more
complex patterns of calls than Shank3e4 – 9 mice (Fig. 2H).
Vocalizations for Shank3+/+ males were longer in duration,
with more frequency bands and greater modulation of frequen-
cies within each call, than Shank3e4 – 9 males. Shank3+/+
females made less complex calls than Shank3+/+ males, but
they were longer in duration with more modulation of fre-
quency bands than Shank3e4 – 9 females. Shank3e4 – 9 females
produced calls as single ‘chirps’ that were devoid of the mul-
tiple frequency bands and complexities of Shank3+/+ controls.
When vocalizations were analyzed as percent durations,
Shank3+/+ mice made more long than short duration calls
(Fig. 2I and J); the converse was observed for Shank3e4 – 9
mice—especially females. When the duration of calls was ana-
lyzed as a function of frequencies, Shank3+/+ males and
females emitted mid-range and high-frequency vocalizations
for longer periods of time than low-frequency calls (Fig. 2K
and L). In contrast, the durations of calls by Shank3e4 – 9
males did not change across frequencies, whereas Shank3e4 –
9 females emitted high-frequency calls for shorter durations
than all other vocalizations and all other mice. Thus,
Shank3e4 – 9 mice emit aberrant ultrasonic vocalizations that
are altered in both duration and frequency.
Motor behaviors are aberrant in Shank3e4 – 9 mice
In a neurophysiological screen, Shank3e4 – 9 mice displayed
mild motor abnormalities as exemplified in tests of vertical
placement and delayed climbing down a vertical pole for
males and females and in contact righting for males (Sup-
plementary Material, Table S2). In the foot-misplacement
test, foot-faults were increased in Shank3e4 – 9 mice
(Fig. 3A). Although the distance traveled in the apparatus
was similar for Shank3e4 – 9 (160.6+ 19.3 cm/5 min) and
Shank3+/+ mice (171.1+ 21.6 cm/5 min), the ratio of foot-
misplacement errors to distance traveled was higher for
mutants (0.23+ 0.2) than for controls (0.13+ 0.01).
Shank3e4 – 9 mice moved more slowly than Shank3+/+
animals, and the Shank3e4 – 9 males were slowest of all
(Fig. 3B). These data indicate that Shank3e4 – 9 mice have dif-
ficulties in fine motor coordination, and mutant males are more
affected than mutant females.
Mice were tested in an open field to determine whether their
motor activities were aberrant. Locomotion was decreased in
Shank3e4 – 9 males compared with all other groups (Fig. 3C).
Additional indices, including time spent in movement,
rearing activity and machine-scored stereotypical activities
did not differ between genotypes (Supplementary Material,
Table S2). Nevertheless, ethological scoring found that both
male and female Shank3e4 – 9 mice participated in more self-
grooming than Shank3+/+ controls. Together, these findings
indicate that Shank3e4 – 9 males engage their environment
less, and that grooming is more frequent in mutants than in
Shank3+/+ controls.
Motor learning was evaluated with the accelerating rotorod
(Fig. 3D and E). The latency to fall was increased across trials
for Shank3+/+ males, indicating motor learning. In contrast,
this latency was unchanged for Shank3e4 – 9 males and was
abbreviated across test trials. No genotype differences were
observed for females. Hence, Shank3e4 – 9 males appear
impaired on motor learning, whereas females are unaffected.
Shank3e4 – 9 mice display repetitive behaviors
Repetitive responses were examined in a novel environment
with a hole-board test and in a familiar environment with a
novel object. With the hole-board, Shank3e4 – 9 mice engaged
in more head pokes (129.4+ 8.1) than Shank3+/+ controls
(101.5+ 6.6); no sex differences were seen. This enhance-
ment in head pokes was not due to reduced anxiety, because
genotype responses were similar in the light–dark emergence
and zero maze tests (Supplementary Material, Table S2).
Moreover, increased head pokes by mutants cannot be
ascribed to novelty-seeking behaviors, because activity in
the center of the open field, and stretch-attend postures or
head-dipping behaviors in the zero maze were similar
between genotypes.
In a home cage, novel object exploration was scored accord-
ing to investigating the object from inside or outside the nest.
Shank3+/+ controls contacted the object more often from
outside than inside the nest (Fig. 3F). Conversely,
Shank3e4 – 9 mice contacted the object more often from the
nest than outside it, and contacts from both locations were
higher than the Shank3+/+ mice. Maps were constructed to
analyze the patterns of object interactions. Regardless of
sex, Shank3e4 – 9 mice made repeated contacts, but only on
certain locations on the object (Fig. 3G and Supplementary
Material, Fig. S3). By comparison, object contacts by
Shank3+/+ controls were not repetitive. When Shank3e4 – 9
mice were not investigating the object, they were engaged in
self-grooming—a behavior that rarely occurred in
Shank3+/+ controls (Fig. 3H). Thus, upon encountering a
novel object in their familiar environment, Shank3e4 – 9 mice
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engage in stereotyped investigations and participate in self-
stimulatory behavior.
Learning and memory are deficient in Shank3e4 – 9 mice
Cognitive performance was examined in Shank3 mice by pre-
pulse inhibition, Morris water maze, novel object recognition
and social transmission of food preference (STFP) tests. For
prepulse inhibition, no genotype differences were observed
for null activity, startle responses or inhibition to the three pre-
pulses (Supplementary Material, Table S2). In the water maze,
swim distance declined across acquisition testing for both gen-
otypes; this reduction occurred less rapidly over the first
3 days for Shank3e4 – 9 mice (Fig. 4A, left). When the hidden
platform was moved from the NE to the SW quadrant, swim
distances initially increased for both genotypes on day 7
(Fig. 4A, right). Subsequently, it decreased for Shank3+/+
controls, but remained higher for Shank3e4 – 9 mice on days
Figure 3. Shank3e4 – 9 mice display abnormalities in motor performance. (A) Shank3e4 – 9(–/–) mice make more foot-misplacements than Shank3+/+ (+/+) con-
trols. (B) Shank3e4 – 9 mice move more slowly than Shank3+/+ mice; Shank3e4 – 9 males are slower than mutant females. (C) Spontaneous locomotor activity in
the open field is lower in Shank3e4 – 9 males than in other groups. (D and E) Motor learning on the accelerating rotorod is deficient in Shank3e4 – 9 males compared
with Shank3+/+ males over all five trials and it is perturbed on trials 4 and 5 compared with Shank3+/+ and Shank3e4 – 9 females. (F) Repetitive frequencies of
object explorations from inside and outside the nest were higher for Shank3e4 – 9 than Shank3+/+ mice. (G) Shank3+/+ males and females typically left the nest to
explore the novel object. Shank3e4 – 9 males spent similar amounts of time exploring the objects from inside and outside the nest than Shank3+/+ males;
Shank3e4 – 9 females spent the most time exploring objects from the nest. (H) Shank3e4 – 9 spent more time self-grooming than Shank3+/+ controls; n ¼ 10
mice/genotype/sex. ∗P , 0.05, Shank3+/+ versus Shank3e4 – 9 mice; #P , 0.05, females versus males within genotype; +P , 0.05, Shank3+/+ females versus
Shank3e4 – 9 males; †P , 0.05, in nest compared with out of the nest.
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8–10. The results for swim time were similar (Supplementary
Material, Fig. S4A). Representative tracings of swim paths
during acquisition supported the swim distance results (Sup-
plementary Material, Fig. S4F, top left). Over reversal
testing, tracings revealed that Shank3e4 – 9 mice swam in
more circular search patterns (e.g. day 12) than the
Shank3+/+ mice (Supplementary Material, Fig. S4F, top
right).
Probe tests for acquisition testing (days 2, 4, 6) failed to
detect significant genotype differences in swim distance
(Fig. 4D and E); all mice swam further in the NE than in
the other three quadrants. When the hidden platform was
moved to the SW quadrant, neither genotype displayed any
quadrant preference on day 8. However, by days 10 and 12,
Shank3+/+ mice swam further in the SW than the other quad-
rants. In contrast, Shank3e4 – 9 mice failed to show any
Figure 4. Shank3e4 – 9 mice are deficient in learning and memory. (A) To reach the hidden platform in water maze, Shank3e4 – 9 mice swam over longer distances on the
first 3 days of acquisition testing than Shank3+/+ mice. When the hidden platform was moved to a new location, swim distance was increased on days 9–11 for
Shank3e4 – 9 mice. (B and C) Visible platform testing with naı̈ve (left) and water-maze experienced (Exp.) (right) Shank3+/+ and Shank3e4 – 9 mice. Naı̈ve
Shank3e4 – 9 males (B, left) and females (C, left) swam over longer distances to reach the visible platform than respective Shank3+/+ controls. Swim distances
for experienced Shank3e4 – 9 males (B, right) and females (C, right) were similar to those of the respective Shank3+/+ controls. (D and E) Swim distances for
Shank3+/+ (D) and Shank3e4 – 9 (E) mice during acquisition (days 2, 4 and 6) and reversal probe tests (days 8, 10 and 12). During acquisition, all mice showed a
marked preference for the NE quadrant. At reversal, Shank3+/+ mice, but not Shank3e4 – 9 mice, developed a significant preference for the SW quadrant. (F)
Shank3 mice were evaluated in the novel object recognition test consisting of training (Train), and tests for STM, LTM and RM. During training, neither genotype
showed any preference for either of the identical objects. Shank3+/+ mice preferred the novel object on the STM, LTM and RM tests; preferences were reduced for
Shank3e4 – 9 mice. (G) Total numbers of object contacts were similar between genotypes. Object contacts declined for Shank3+/+ mice over LTM and RM testing;
contacts remained high for Shank3e4 – 9 mice. (H) In the STFP test, no genotype differences were noted for STM. Shank3e4 – 9 mice showed a dramatically reduced
preference for the demonstrator diet during the LTM and RM tests. For all tests, n ¼ 10 mice/genotype/sex. ∗P , 0.05, Shank3+/+ versus Shank3e4 – 9 mice; #P ,
0.05, females versus males within genotype; ^P , 0.05, naı̈ve Shank3e4 –9 mice versus experienced Shank3e4 – 9 mice; §P , 0.05, versus NE quadrant; XP , 0.05,
versus SW quadrant; †P , 0.05, compared with the STM test.
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quadrant preference. An examination of swim times revealed
similar results (Supplementary Material, Fig. S4D and E).
Although tracings of the swim paths during acquisition
probe tests were similar between genotypes (Supplementary
Material, Fig. S4F, bottom), the wide and circling patterns
of Shank3e4 – 9 mice became more prominent by the last day
of reversal. Together, these results suggest that spatial
memory and plasticity may be deficient in Shank3e4 – 9 mice.
The impaired performance in reversal training may also indi-
cate inflexibility of behaviors in Shank3e4 – 9 mice.
Over the first five trials of the visible platform test, naı̈ve
Shank3e4 – 9 males swam further to reach the platform than
naı̈ve Shank3+/+ males; naı̈ve mutant females swam further
on the first two trials than naı̈ve female controls (Fig. 4B
and C, left). Notably, naı̈ve Shank3e4 – 9 females swam over
shorter distances on the first six trials than naı̈ve Shank3e4 – 9
males. To determine whether the protracted swim times of
naı̈ve Shank3e4 – 9 mice could be attributed to delayed learning
or to performance issues, naı̈ve and experienced mice were
compared. Although swim distances for naı̈ve and experienced
Shank3+/+ controls did not differ (Fig. 4B and C, right),
experienced Shank3e4 – 9 males and females swam over
shorter distances than respective naı̈ve mutants. Analyses of
swim time revealed similar results (Supplementary Material,
Fig. S4B and C). Hence, deficiencies of naı̈ve Shank3e4 – 9
mice appear to be due to test familiarization or delayed learn-
ing, rather than specific sensory, motor or motivational
abnormalities.
Episodic short-term (STM), long-term (LTM) and remote
memory (RM) were analyzed using a novel object recognition
test. Preferences for the novel object by Shank3+/+ mice were
high and unchanged across the STM, LTM and RM tests
(Fig. 4F). In contrast, novel object preference was decreased
for Shank3e4 – 9 mice. Since poor performance could be attrib-
uted to object neophobia, the duration of object contacts and
the numbers of object contacts were examined. The duration
of object contacts was similar for both genotypes (Supplemen-
tary Material, Table S3). Shank3+/+ and Shank3e4 – 9 mice also
contacted the objects similar numbers of times during training
and the STM test (Fig. 4G). However, Shank3+/+ mice made
fewer object contacts than mutants during the LTM and RM
tests, and these contact numbers were less than those during
training and the STM test. In contrast, object contacts were
not reduced across tests for Shank3e4 – 9 animals.
In the STFP test, Shank3+/+ controls maintained a strong
preference for the demonstrator diet during the STM, LTM
and RM tests, with little change across test-days (Fig. 4H).
However, this preference was lost by Shank3e4 – 9 mice
during the LTM and RM tests. Despite impairments in LTM
and RM in mutants, no genotype differences were discerned
for time spent interacting with the demonstrator mouse, the
total amount of diets eaten or times investigating the diets
on each test-day (Supplementary Material, Table S3). Collec-
tively, the object recognition and STFP results indicate that at
least LTM and RM are impaired in Shank3e4 – 9 mice.
Dendritic spine morphology is altered in Shank3e4 – 9 mice
Brain anatomy of Shank3e4 – 9 mice at 2–4 months of age
appeared normal by gross, histological and ultrastructural
analyses with light and electron microscopy (Fig. 5E and F
and Supplementary Material, Fig. S5A). To examine dendritic
spine morphology, hippocampal slice cultures were prepared
from pups 6–7 days old and neurons were transfected biolisti-
cally with a GFP plasmid (Supplementary Material,
Fig. S5D). Although no genotype differences were detected in
dendritic branching (Fig. 5A) or in spine densities and spine-
head sizes (Fig. 5B and D), dendritic spines were significantly
longer in Shank3e4 – 9 (1.23+ 0.07 mm, 678 spines from 7
mice) than Shank3+/+ mice (0.76+ 0.06 mm, 1183 spines
from 8 mice; P , 0.002) (Fig. 5C). Interestingly, overall,
Shank3e4 – 9 mice had more thin spines than Shank3+/+ controls;
however, this difference did not achieve statistical significance
(Shank3+/+ mice: stubby 151, mushroom 283 and thin spines
691; Shank3e4 – 9 mice: stubby 77, mushroom 172 and
thin spine 432, P . 0.05). The ratio of stubby- and mushroom-
shaped spines to thin spines was borderline lower in Shank3e4 – 9
mice [Shank3+/+ mice: (151 + 283)/691 ¼ 0.63+ 0.06;
Shank3e4 – 9 mice: (77 + 172)/432 ¼ 0.58+ 0.07), P ¼
0.052]. We used Golgi impregnation to examine dendritic
spine morphology in CA1 hippocampus of 4- and
10-week-old Shank3e4 – 9 mice (Fig. 5G and H). Spine density
in the CA1 hippocampus was reduced and spine length was sig-
nificantly increased in 4-week-old Shank3e4 – 9 mice compared
with Shank3+/+ mice (spine density: +/+, 1.49+ 0.09/mm;
–/–, 1.24+ 0.07/mm, P ¼ 0.03; spine length: +/+, 0.94+
0.02 mm; –/–, 1.05+ 0.03 mm, P , 0.003) (Fig. 5I and J).
Cumulative frequencies for spine length are shown in Sup-
plementary Material, Fig. S5E and F. In contrast, spine
density was not significantly reduced but spine length was
increased in 10-week-old Shank3e4 – 9 compared with
Shank3+/+ mice (spine density: +/+, 1.70+ 0.04/mm; –/–,
1.63+ 0.03/mm, P . 0.05; spine length: +/+, 0.91+
0.02 mm; –/–, 0.85+ 0.01 mm, P ¼ 0.01) (Fig. 5K and L).
No gender difference was noted. The reduced density and
increased spine length in 4-week-old Shank3e4 – 9 mice are con-
sistent with the observations of siRNA-mediated knockdown of
Shank3 in cultured neurons (9). The discrepancy for the spine
density between cultured neurons of newborns and Golgi
impregnation of 4-week-old mice and between 4- and
10-week-old mice may be due to differences in the sensitivity
of the methods—although it could also reflect developmental
differences.
Altered PSD proteins in Shank3e4 – 9 mice
To examine whether the composition of PSD proteins was
altered in Shank3e4 – 9 animals, we performed quantitative
immunoblot analyses for candidate Shank3-interacting proteins
(Supplementary Material, Table S4). No genotype differences
were detected in the levels of cytosolic proteins extracted
from brain (Supplementary Material, Fig. S6A and B). In con-
trast, when levels of synaptic proteins from the PSD-I fraction
were examined, GKAP and Homer1b/c were reduced in
Shank3e4 – 9 compared with Shank3+/+ control PSD fractions
(85.2+ 6.1% of Shank3+/+ for GKAP, P ¼ 0.03, n ¼ 11
mice/genotype; 66.1+ 4.2% of Shank3+/+ for Homer1b/c, P
, 0.001, n ¼ 16 mice/genotype); no genotype distinctions
were observed for other synaptic proteins at the PSD (Fig. 6A
and C and Supplementary Material, Fig. S6C and D). No
3100 Human Molecular Genetics, 2011, Vol. 20, No. 15
significant sex differences were noted. The AMPAR subunit
GluA1 and the NMDAR subunit NR2A were significantly
reduced in membrane (SPM) fractions from Shank3e4 – 9 mice
(72.0+ 6.2% of Shank3+/+ for GluA1, P , 0.002, n ¼ 8
mice/genotype; 75.0+ 8.3% of Shank3+/+ for NR2A, P ¼
0.02, n ¼ 8 mice/genotype). Levels of other receptor subunits,
including the AMPAR GluA2 and the NMDAR NR2B subunits,
were not significantly altered in SPM fractions from Shank3e4 – 9
mice (Fig. 6B and D). No sex differences were observed.
Reduced levels of GluA1 and Homer1b/c were observed in
Shank3e4 – 9 heterozygotes compared with Shank3+/+ controls,
but the differences were more subtle than between the homozy-
gous mutant Shank3e4 – 9 and Shank3+/+ controls. In addition,
we also detected an interaction between Shank3 and
Homer1b/c by co-immunoprecipitation (Supplementary
Material, Fig. S6E and F).
The distribution of synaptic PSD-I proteins was further ana-
lyzed by immunostaining of hippocampal neuronal cultures
from Shank34 – 9 mice. Consistent with the quantitative immuno-
blots, immunostaining of Homer1b/c and GluA1 were reduced
in Shank3e4 – 9 mice (Fig. 6E)—as confirmed by quantitative
analyses of Homer1b/c and GluA1 puncta (87.2+ 2.1 % of
Shank3+/+ for Homer1b/c, P , 0.01, n ¼ 17 cells/genotype;
80.3+ 3.4% of Shank3+/+ for GluA1, P , 0.001, n ¼ 27
cells/genotype) (Fig. 6F). The puncta sizes of immunostaining
for Homer1b/c and GluA1 were also reduced in Shank3e4 – 9
mice (Supplementary Material, Fig. S5G). Although GKAP
(n ¼ 8/genotype) and NR2A (n ¼ 8/genotype) immunostaining
Figure 5. Dendritic spine morphology was altered in Shank3e4 – 9 mice. (A) Low (left) and high (right) resolution images of EGFP-expressing pyramidal neurons
from Shank3+/+ (+/+) and Shank3e4 – 9 (–/–) mice. Quantification of spine density (B), spine length (C) and spine-head area (D). A significant difference was
revealed in spine length but not for spine density or spine-head area (spine length: 1.23+0.07 mm, 678 spines from 7 Shank3e4 – 9 mice; and 0.76+0.06 mm,
1183 spines from 8 Shank3+/+ mice; ∗P , 0.002, Shank3+/+ versus Shank3e4 – 9 mice). (E and F) Representative electron micrographs of hippocampal CA1
striatum radiatum synapses from Shank3+/+and Shank3e4 – 9 mice. The PSD is visible as an electron-dense layer adjacent to the post-SPM
(scale bar ¼ 0.1 mm). A total of 71 synapses from 3 Shank3+/+ mice and 69 synapses from 3 Shank3e4 – 9 mice were measured. There were no significant geno-
type changes in PSD length or thickness. (G and H) Representative images from Golgi staining of 4-week (G) and 10-week-old (H) Shank3+/+ and Shank3e4 – 9
mice. Scale bar ¼ 5 mm. (I and J) Spine density (I) and spine length (J) in 4-week-old Shank3e4 – 9 mice (n ¼ 15 cells from 3 +/+ mice and n ¼ 14 cells from 3
–/– mice). A total of 731 spines from Shank3+/+ and 649 spines from Shank3e4 – 9 mice were measured (∗P ¼ 0.03 for spine density and P , 0.003 for spine
length). (K and L) Spine density (K) and spine length (L) in 10-week-old Shank3e4 – 9 mice (n ¼ 40 cells from 3 +/+ mice; n ¼ 31 cells from
3 –/– mice). A total of 992 spines from Shank3+/+ and 707 spines from Shank3e4 – 9 mice were measured (∗P ¼ 0.01 for spine length).
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were decreased in Shank3e4 – 9 mice, this difference was not stat-
istically significant, perhaps reflecting the differing sensitivities
of these methods, or differences in synaptic versus non-synaptic
pools of these molecules. Together, these findings indicate that
specific synaptic scaffolding proteins and receptor subunits are
altered by the disruption of major Shank3 isoforms.
Synaptic plasticity is impaired in Shank3e4 – 9 mice
The reductions in GluA1 subunits and other PSD proteins in
Shank3e4 – 9 mice suggest a possible role for Shank3 in synap-
tic function. To examine this possibility, we analyzed excit-
atory synaptic transmission and plasticity at the CA1
Shaffer-collateral synapses in 2–4-month-old Shank3e4 – 9
mice, using field post-synaptic potential (fPSP) recordings.
Shank3e4 – 9 mice showed reduced post-tetanic potentiation
compared with Shank3+/+ animals (Shank3+/+ mice: 195+
22% baseline fPSP slope, n ¼ 12; Shank3e4 – 9 mice:
150+ 10% baseline fPSP slope, n ¼ 8; P , 0.001)
(Fig. 7A). Moreover, Shank3e4 – 9 mice exhibited reduced hip-
pocampal long-term potentiation (LTP) (Shank3+/+ mice:
165+ 9% baseline fPSP slope, n ¼ 12; Shank3e4 – 9 mice:
127+ 6% baseline fPSP slope, n ¼ 8; P , 0.001) (Fig. 7A).
No sex differences were observed. Despite the plasticity
defect, there were no apparent differences in basal synaptic
transmission between Shank3+/+ and Shank3e4 – 9 mice. The
Figure 6. Altered protein composition in PSD and SPM fractions of Shank3e4 – 9 mice. Immunoblot analyses of PSD (A) and SPM (B) fractions from individual
Shank3+/+ and Shank3e4 – 9 mice for the indicated proteins. Pan-Shank (Shank1–3) antisera revealed an absence of the Shank3 band in Shank3e4 – 9 mice.
Homer1b/c and GKAP in the PSD and GluA1 and NR2A in the SPM are reduced in Shank3e4 – 9 mice. (C and D) Quantification of proteins in PSD fractions
based on results shown in (A) and (B), respectively, normalized using actin for protein quantification. There is a significant reduction in the levels of the indicated
proteins in Shank3e4 – 9 compared with Shank3+/+ samples. Homer1b/c (n ¼ 16 each/genotype, ∗P , 0.001), GKAP (n ¼ 11 each/genotype,∗P ¼ 0.03), GluA1
(n ¼ 8 each/genotype,∗P , 0.002) and NR2A (n ¼ 8 each/genotype, ∗P ¼ 0.02). No sex difference was observed. There is no significant differences for other
proteins including Homer1a (n ¼ 11 each/genotype), GluA2 (n ¼ 8 each/genotype) and NR2B (n ¼ 8 each/genotype). (E) Hippocampal neurons in dissociated
culture (16–18 DIV) from Shank3+/+ or Shank3e4 – 9 mice (n ¼ 8 each/genotype) were immunostained with bassoon antibody (red) and with GKAP, Homer1b/c,
GluA1(C-terminus) or NR2A antibodies (green). Merged images shown on the right. Scale bar ¼ 5 mm. (F) Normalized integrated density for the indicated
proteins (Shank3+/+ ¼ 1.00). Significant differences were found for Homer1b/c and GluA1 proteins between Shank3+/+ and Shank3e4 – 9 samples
(∗P , 0.01 for Homer1b/c and ∗P , 0.001 for GluA1). No significant differences were found for GKAP and NR2A.
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input–output (I/O) curves (Shank3+/+ mice: n ¼ 23;
Shank3e4 – 9 mice: n ¼ 23; P . 0.05) (Fig. 7B), the magnitude
of the evoked fiber volley (Shank3+/+ mice: n ¼ 8; Shank3e4 –
9 mice: n ¼ 9; P . 0.05) (Fig. 7C) and the fiber volley versus
fPSP slope (Shank3+/+ mice: n ¼ 8; Shank3e4 – 9 mice: n ¼ 9;
P . 0.05) (Fig. 7C, insert) measurements were similar
between genotypes. Finally, the paired-pulse ratio of the
synaptically evoked fPSPs was also comparable (Shank3+/+
mice: n ¼ 13; Shank3e4 – 9 mice: n ¼ 14; P . 0.05)
(Fig. 7D). These findings suggest that, when not challenged
by high-frequency stimulation, the probability of neurotrans-
mitter release at these synapses is equivalent between adult
Shank3+/+ and Shank3e4 – 9 mice. However, we cannot
exclude the possibility that there may be more significant
Figure 7. Impaired synaptic plasticity and activity-dependent AMPAR GluA1 distribution in Shank3e4 – 9 mice. (A) Summary graph of LTP experiments and repre-
sentative fPSP traces in Shank3+/+ (+/+) and Shank3e4 – 9 (–/–) mice (+/+, n ¼ 12 slices from 8 mice; –/–, n ¼ 8 slices from 8 mice). Tetanic stimulation (100 Hz,
1 s × 2) was applied at 15 min. LTP was significantly impaired in Shank3e4 – 9 mice. (B) Input–output relationships of fPSPs of Shank3+/+ (+/+, n ¼ 23 slices from
8 mice) and Shank3e4 – 9 mice (–/–, n ¼ 23 slices from 8 mice) were not significantly different. (C) Summary graph of the fiber volley (FV) amplitude during the
input–output test of Shank3+/+ (+/+, n ¼ 8 slices from 8 mice) and Shank3e4 – 9 mice (–/–, n ¼ 9 slices from 8 mice). Insert depicts FV versus fPSP relationship.
(D) Paired-pulse ratio at different inter-stimulus intervals in Shank3+/+ (+/+, n ¼ 13 slices from 8 mice) and Shank3e4 – 9 mice (–/–, n ¼ 14 slices from 8 mice). (E)
Sample traces and summary graphs depicting mIPSC amplitude and frequency in Shank3+/+ (n ¼ 13 cells from 5 mice) and Shank3e4 – 9 (n ¼ 14 cells from 5 mice)
animals. No significant differences were observed between genotypes. (F) Sample traces and summary graphs depicting mEPSC amplitude and frequency in
Shank3+/+ (n ¼ 14 cells from 5 mice) and Shank3e4 – 9 (n ¼ 14 cells from 5 mice) animals. No significant differences were observed between genotypes. (G) Atte-
nuated response of activity-dependent distribution of surface GluA1. Hippocampal neurons in dissociated culture (16–18 DIV) from Shank3+/+ and Shank3e4 – 9
mice were treated with a chemical LTP protocol. Neurons were sequentially stained for surface GluA1 (N-terminus) (green) and bassoon (red) under non-permeant
and permeant conditions, respectively. A significant increase of surface GluA1 staining after cLTP was seen in Shank3+/+ neurons; this increase was much attenuated
in Shank3e4 – 9 neurons. (H) The normalized integrated density of surface GluA1. Staining intensity was significantly increased after cLTP in cultured neurons from
Shank3+/+, but not from Shank3e4 – 9 mice. Shank3+/+, n ¼ 17 cells; Shank3e4 – 9, n ¼ 12 cells. ∗P , 0.001, Shank3+/+ versus Shank3e4 – 9 mice. ^P , 0.01,
cLTP-stimulated Shank3+/+ versus Shank3e4 – 9 mice.
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synaptic defects earlier in development that are overcome
through age or homeostatic mechanisms.
To further assess possible differences in neurotransmitter
release probability or postsynaptic strength, we analyzed min-
iature excitatory post-synaptic currents (mEPSCs) and minia-
ture inhibitory post-synaptic currents (mIPSCs), using
voltage-clamp recordings (Fig. 7E and F). Average mEPSC
amplitude (Shank3+/+ mice: 12.7+ 0.5 pA, n ¼ 14;
Shank3e4 – 9 mice: 13.0+ 0.4 pA, n ¼ 14; P . 0.05) and
frequency (Shank3+/+ mice: 0.62+ 0.09 Hz, n ¼ 14;
Shank3e4 – 9 mice: 0.65+ 0.09 Hz, n ¼ 14; P . 0.05) were
similar between Shank3e4 – 9 and Shank3+/+ mice, confirming
that normal basal excitatory synaptic transmission can develop
in the absence of expression of major Shank3 isoforms. Inhibi-
tory synaptic transmission, as measured by mIPSC frequency
(Shank3+/+ mice: 3.0+ 0.8 Hz, n ¼ 13; Shank3e4 – 9 mice:
4.5+ 0.7 Hz, n ¼ 14; P . 0.05) and amplitude
(Shank3+/+ mice: 34.9+ 3.7 pA, n ¼ 13; Shank3e4 – 9 mice:
38.3+ 2.2 pA, n ¼ 14; P . 0.05), was also similar between
genotypes. Together, these results indicate that, despite
normal basal synaptic transmission, Shank3 deletion impairs
hippocampal CA1 synaptic plasticity.
Impaired activity-dependent GluA1 redistribution
in Shank3e4 – 9 neurons
The reduced GluA1 levels suggest that Shank3 deficiency may
alter activity-dependent AMPAR dynamics at the synapse,
which might underlie the impaired hippocampal LTP. To
address this point, we applied a chemical LTP (cLTP) protocol
to cultured neurons. cLTP was associated with a significant
increase in surface GluA1 subunits in Shank3+/+ mice
(Fig. 7G); this response was significantly attenuated in
Shank3e4 – 9 mice. Consistent with this result, after surface
GluA1 immunostaining, the staining intensity of puncta
increased in an activity-dependent manner in Shank3+/+ (n ¼
17, control: 0.99+ 0.13; cLTP: 3.02+ 0.41), but not in
Shank3e4 – 9 cells (n ¼ 12, control: 1.16+ 0.19;
cLTP: 1.85+ 0.16. P , 0.001 for Shank3+/+ versus
Shank3e4 – 9 in control cells and P , 0.01 for Shank3+/+
versus Shank3e4 – 9 in cLTP stimulated cells) (Fig. 7H). Like-
wise, the size of stained puncta after surface GluA1 immunos-
taining was also decreased in Shank3e4 – 9 mice
(Supplementary Material, Fig. S5H). These observations
suggest that impaired activity-dependent trafficking of GluA1
subunits in Shank3e4 – 9 neurons may be a cellular mechanism
underlying deficient hippocampal LTP in Shank3e4 – 9 mice.
DISCUSSION
SHANK3 mutations in PMS and ASD
SHANK3 maps to the critical region of chromosome 22q13.3
deletion syndrome or PMS and this gene is thought to play a
key role in the ASD and cognitive dysfunction in this disorder.
because many cases have small deletions only disrupting
SHANK3 (10–13,22,37). Other genes in the region may also
contribute to the condition (23). Microdeletions and de novo
missense and frame-shift mutations in SHANK3 have been
reported in a small subgroup of ASD cases; these individuals
are often comorbid with intellectual disability (16–21). ASD
patients with missense and frame-shift mutations in SHANK3
may have loss of some but not all SHANK3 isoforms. At
this point, it is unclear which SHANK3 point mutations in
ASD patients behave as loss- or gain-of-function in vivo.
The Shank3 mutation in our mice includes exons 4–9, result-
ing in the loss of Shank3a and Shank3b, the two major Shank3
mRNA transcripts in the brain. ASD patients with heterozy-
gous missense mutations in exons 5–9 of SHANK3 have
been identified (16,18,19). We have conducted our studies in
Shank3 homozygous mutants to identify functional roles of
Shank3 in vivo. Our findings support an important role for
SHANK3 in PMS- and ASD-like responses.
We found that the combination of five intragenic promoters
and alternatively spliced exons results in a complex pattern of
mRNA species both in mice and humans (data not shown for
human), and these species presumably produce a sizable
number of Shank3 protein isoforms with unique protein
domain structures, including some that are neuron- or astrocyte-
specific (38). Each domain mediates specific protein–protein
interactions at synapses, raising the possibility that each
Shank3 isoform may play a distinct role in synaptic function
and may make distinct contributions to the disease processes
of ASD. The deletion of exons 4–9 physically removed the
ANK domain but it also disrupted other domains encoded by
the Shank3a and Shank3b isoforms because of a frame-shift
change. Our data indicate an isoform-specific role of Shank3
in synaptic function. Since SHANK3 mutations in ASD appear
isoform-specific, we speculate that different SHANK3 isoforms
may lead to different clinical presentations.
Shank3e4 – 9 mice provide a model for ASD
In humans, the diagnosis of ASD is usually based upon behav-
ioral assessment. ASD patients are typically impaired in social
and communication skills and engage in repetitive and stereo-
typed behaviors (24–26). Cognitive disabilities and movement
disorders are common comorbidities in ASD (27–29). Inter-
estingly, de novo missense mutations in exons 5–9 and micro-
deletions of the entire SHANK3 gene in heterozygotes have
been reported in individuals who meet the diagnosis for
ASD (17–19). In ASD cases with microdeletions, haploinsuf-
ficiency of SHANK3 is apparent, but whether point mutations
of SHANK3 behave as loss- or gain-of-functions in vivo is not
known. Since our Shank3e4 – 9 homozygous mutants present
with multiple behavioral abnormalities that are reminiscent
of key features ASD may support a conclusion of
loss-of-function as a mutational mechanism in these cases.
ASD children often fail to develop normal social inter-
actions. Similarly, autistic-like mice fail to demonstrate pre-
ference for social novelty (39). In our sociability test,
Shank3e4 – 9 mice showed context-specific sociability. When
familiar non-social and novel social stimuli were paired,
Shank3+/+ controls showed affiliation for the latter, whereas
Shank3e4 – 9 mutants demonstrated little or no social affiliation.
By comparison, when confronted with a novel and a familiar
social stimulus, both genotypes showed social preference for
the novel animal. These findings indicate that Shank3e4 – 9
animals can develop a social reference when two social
stimuli are paired, but choose not to socially interact given a
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choice between non-social and social stimuli. This failure to
interact is observed also in the dyadic social test, where
Shank3e4 – 9 mice fail to reciprocate social exchanges and
engage in non-social self-directed behaviors like self-
grooming and sifting. This decrease in sustained social
exchanges probably contributes to the reduced social investi-
gations by their C3H partners. Interestingly, a decay in reci-
procal exchanges is proposed to be a hallmark of
autistic-like responses in mice (39).
Vocal communication is perturbed in Shank3e4 – 9 mice;
ultrasonic calls in Shank3e4 – 9 mice are abbreviated and lack
the complexity of frequency modulation of the Shank3+/+
controls. The increased numbers of calls by Shank3e4 – 9
males and reduced complexity by both mutant males and
females are reminiscent of the ‘echolalia’ and ‘monotone
speech’ observed in ASD (27,40). In fact, many of the calls
by Shank3e4 – 9 mice are characterized by single notes or
short non-complex whistles of single elements.
Shank3e4–9 mice engage in more stereotyped and repetitive
behaviors than Shank3+/+ controls. Self-grooming by mutants
is evident during social interactions with an unfamiliar C3H
mouse in the dyadic test, and in the home cage in the presence
of a novel object. Grooming, however, does not appear to be
due to anxiety-like behaviors (41,42), since Shank3e4–9
animals do not display these responses in the light–dark box or
zero maze. Enhanced repetitive behaviors are seen also in the
hole-board and in the home cage novel object tests. These
responses suggest that the behavioral repertoire of Shank3e4–9
mice may be more restricted and less malleable than that of the
Shank3+/+ controls. Indeed, decreased plasticity of behavior is
evident during reversal testing in the Morris water maze, where
Shank3e4– 9 mice are unable to learn the new location of the
hidden platform. Interestingly, ASD is also associated with
enhanced stereotyped responses and impairments in novelty pro-
cessing, with reductions in the ability to modify ongoing behavior
in response to changing environmental conditions (43,44).
The Shank3e4 – 9 mutants also demonstrate abnormalities in
motor performance and learning and memory–comorbidities
often accompanying ASD and PMS in humans (13,27–29).
The motor deficiencies in the gait and foot-misplacement
tests are evident in both sexes, whereas performance on the
rotorod is impaired only in Shank3e4 – 9 males. Spatial
memory is slightly perturbed in the Shank3e4 – 9 mice; acqui-
sition was delayed, although accompanying probe test
responses were similar to those of the Shank3+/+ controls.
However, mutants failed the task when the hidden platform
was moved to a new location, suggesting that behavioral plas-
ticity is restricted. In addition, long-term and remote episodic
and social memories are aberrant in Shank3e4 – 9 mice. These
deficiencies in hippocampally based behaviors are concordant
with the impaired hippocampal LTP observed in the Shank3
mutant mice (45,46).
It should be emphasized that Shank3e4 – 9 males display a
more severe phenotype than females in motor performance
despite the absence of significant sex differences in the bio-
chemical, morphological and electrophysiological studies. In
this context, it is noteworthy that human males are four to
six times more likely than females to receive a diagnosis of
ASD (27,30,31), though possible sex differences have not
been analyzed in ASD patients with SHANK3 mutations.
Collectively, the abnormal social behaviors, communication
patterns and repetitive behaviors support the Shank3 mutant
mouse as a valuable model for further investigations of the
neurophysiological basis of ASD. This mouse also provides
an important basis to further investigate behavioral profiles
in Shank3 heterozygous mutant mice that may have greater
relevance for PMS and ASD, which are associated with
SHANK3 mutations.
Shank3, AMPAR trafficking and synaptic plasticity
Homer1b/c and GKAP proteins are decreased in the PSD of
Shank3e4 – 9 mice, suggesting that Shank3 may recruit or
prevent the removal of these proteins at synapses (1,2,47),
thus perturbing postsynaptic signal transduction. In vitro, the
ANK domain of Shank3 is known to mediate the interaction
between synaptic glutamate receptor complexes and cyto-
skeletal proteins at the PSD (7,48). Direct interactions
between Shank3 and GluA1, GKAP and Homer1b/c have
been reported (1,2,8). In Shank3e4 – 9 mutant mice, all
domains in two major Shank3 protein isoforms were disrupted.
We find here that activity-dependent redistribution of the
GluA1 of the AMPAR is attenuated, LTP in CA1 hippo-
campus is impaired and spine morphology is subtly altered
in Shank3e4 – 9 mice. We speculate that the deficits in activity-
dependent trafficking of GluA1 in Shank3-deficient neurons
may be caused by the disrupted interactions between Shank3
and GKAP and Homer1b/c, perhaps leading to impaired exo-
cytic or endocytic recycling of AMPAR trafficking. As
expected with deficiencies in GluA1 trafficking and hippocam-
pal LTP, Shank3e4 – 9 animals are impaired on hippocampus-
based behavioral tasks, including the Morris water maze,
novel object recognition and STFP. Human patients with del-
etions or point mutations in SHANK3, who present with
moderate-to-severe intellectual disability, may harbor many
of the same biochemical and cellular deficiencies found in
our mutants.
Shank family proteins and neuropsychiatric disorders
Recent genetic studies indicate that SHANK family proteins
play an important role in other neurodevelopmental and neu-
ropsychiatric disorders. For instance, point mutations or
microdeletions of SHANK2 occur in cases of ASD and intel-
lectual disability (49,50), whereas mutations in SHANK3
have been identified in individuals with schizophrenia
(20,21). Although Shank proteins share similar domain struc-
tures, their expression patterns and subcellular localizations
within the PSD are different (36,51). Similar to our
Shank3e4 – 9 animals, Shank1– / – mice have reduced levels of
Homer1b/c and GKAP proteins, whereas GluA1 and NR2A
subunit levels are normal (52). Maturation of dendritic
spines is perturbed also in Shank1– / – mice. Nevertheless,
basal synaptic transmission is weak, whereas hippocampal
CA1 synaptic LTP is intact. Additionally, spatial memory
and social behavior are not impaired in Shank1– / – mice
(52,53). These biochemical, cellular, morphological and be-
havioral distinctions indicate that mutations in these Shank
family protein genes can produce very different phenotypes.
Moreover, since mutations within SHANK3 itself are
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associated with ASD, intellectual disability and schizophrenia,
it remains to be determined how these different mutations
produce these varied disorders. Combinations of human
genetic studies with murine-targeted exon deletions of Shank
family members may provide new insights into basic mechan-
isms that underlie these and other neuropsychiatric conditions.
MATERIALS AND METHODS
Generation of Shank3 mutant mice, mouse breeding,
animal care
The standard protocol for gene targeting in embryonic stem
cells and production of knockout mice was previously
described (32) (see Supplementary Material, Methods, for
details). All experiments were conducted with approved proto-
cols from the Institutional Animal Care and Use Committee at
Duke University.
Neuronal culture, cLTP and immunocytochemistry
Primary hippocampal cultures were prepared from brains of
newborn mouse pups at postnatal day 0 (P0) to P1 as described
previously (54,55) with some modifications. The protocols for
cLTP and immunocytochemistry are found in Supplementary
Material, Methods.
Spine morphology in hippocampal slice culture and
two-photon laser scanning microscopy
Organotypic hippocampal slices were prepared from mouse
pups postnatal 6–7 days of age and spines were imaged as
described (55) (see Supplementary Material, Methods, for
details).
Hippocampal slice preparation and electrophysiology
Hippocampal slices were prepared from 2–4-month-old mice.
The recording protocol has been described (56,57) and is
included in Supplementary Material, Methods.
Behavioral testing
Shank3 mutant mice and their wild-type littermates were at
3–4 months of age at the time of testing. The estrous cycle
in females was not controlled. Descriptions of the many of
the behavioral methods have been published (42,58–60);
more detailed descriptions of all the methods can be found
in Supplementary Material, Methods.
Statistics
All data were analyzed with SPSS 11 (SPSS, Inc., Chicago, IL,
USA) and expressed as means+SEM. Descriptions of the
statistical methods can be found in Supplementary Material,
Methods. Additionally, all statistical behavioral results can
be found in Supplementary Material, Results.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG online.
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